ZFIN ID: ZDB-FISH-180615-1
Fish name: TU + MO1-ptgs1
Genotype: TU
Targeting Reagent: MO1-ptgs1
HUMAN DISEASE MODELED by TU + MO1-ptgs1
No data available
GENE EXPRESSION
Gene expression in TU + MO1-ptgs1
Reporter gene expression No data available
PHENOTYPE
Phenotype in TU + MO1-ptgs1
Phenotype Conditions Figures
brain hydrocephalic, abnormal control Fig. S3 from Marra et al., 2019
pericardium edematous, abnormal control Fig. S3 from Marra et al., 2019
pronephric distal early tubule slc12a1 expression increased distribution, abnormal standard conditions Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal early tubule increased size, abnormal standard conditions Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal early tubule size, ameliorated chemical treatment by environment: 16,16-dimethylprostaglandin E2 Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal early tubule slc12a1 expression spatial pattern, ameliorated chemical treatment by environment: 16,16-dimethylprostaglandin E2 Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal late tubule slc12a3 expression decreased distribution, abnormal standard conditions Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal late tubule decreased size, abnormal standard conditions Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal late tubule size, ameliorated chemical treatment by environment: 16,16-dimethylprostaglandin E2 Fig. 4 with image from Poureetezadi et al., 2016
pronephric distal late tubule slc12a3 expression spatial pattern, ameliorated chemical treatment by environment: 16,16-dimethylprostaglandin E2 Fig. 4 with image from Poureetezadi et al., 2016
pronephric duct odf3b expression decreased distribution, abnormal chemical treatment by environment: prostaglandin E2 Fig. 1 with image from Marra et al., 2019
pronephric duct jag2b expression decreased distribution, abnormal control Fig. 2 from Marra et al., 2019
pronephric duct pax2a expression decreased distribution, abnormal control Fig. 2 from Marra et al., 2019
pronephric duct odf3b expression decreased distribution, abnormal control Fig. 1 with image from Marra et al., 2019
pronephric duct multi-ciliated epithelial cell decreased amount, abnormal control Fig. 1 with imageFig. 2 from Marra et al., 2019
pronephric duct multi-ciliated epithelial cell decreased amount, ameliorated chemical treatment by environment: prostaglandin E2 Fig. 1 with image from Marra et al., 2019
pronephric duct multi-ciliated epithelial cell has fewer parts of type multi-ciliated epithelial cell cilium, abnormal control Fig. 4 from Marra et al., 2019
pronephric duct multi-ciliated epithelial cell has normal numbers of parts of type multi-ciliated epithelial cell ciliary basal body, normal control Fig. 4 from Marra et al., 2019
pronephric proximal convoluted tubule multi-ciliated epithelial cell decreased amount, abnormal control Fig. 3 from Marra et al., 2019
pronephric proximal straight tubule multi-ciliated epithelial cell odf3b expression decreased distribution, abnormal control Fig. 3 from Marra et al., 2019
pronephros has fewer parts of type pronephros multi-ciliated epithelial cell, abnormal standard conditions Fig. 4 with image from Chambers et al., 2020
trunk curved ventral, abnormal standard conditions Fig. 4 with image from Chambers et al., 2020

CITATIONS  (3)